HMM302 - Innovations in Medical Biotechnology
| Year: | 2025 unit information |
|---|---|
| Enrolment modes: | Trimester 1: Burwood (Melbourne), Waurn Ponds (Geelong) |
| Credit point(s): | 1 |
| EFTSL value: | 0.125 |
| Prerequisite: | HMM101 or HMM201 |
| Corequisite: | Nil |
| Incompatible with: | Nil |
| Study commitment | Students will on average spend 150 hours over the teaching period undertaking the teaching, learning and assessment activities for this unit. This will include educator guided online learning activities within the unit site. |
| Scheduled learning activities - campus | 1 x 2 hour online live lecture per week |
Content
This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.
Unit Fee Information
Fees and charges vary depending on the type of fee place you hold, your course, your commencement year, the units you choose to study and their study discipline, and your study load.
Tuition fees increase at the beginning of each calendar year and all fees quoted are in Australian dollars ($AUD). Tuition fees do not include textbooks, computer equipment or software, other equipment or costs such as mandatory checks, travel and stationery.
For further information regarding tuition fees, other fees and charges, invoice due dates, withdrawal dates, payment methods visit our Current Students website.